Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer

Table 2 Characteristics of patients with colon cancer in GSE39582

Clinical characteristics	NEO1 expression			Chi-square	P value
Clinical characteristics	Total	High	Low	Chi-square	P value
Gender
Male	322	165	157	0.383	0.536
Female	263	128	135
Age
< 65	216	106	110	0.165	0.685
≥ 65	368	187	181
T stage
Tis-T2	65	38	27	10.955	0.000074***
T3-T4	498	166	332
N stage
N0	314	180	134	14.332	0.000153***
N1-N3	243	100	143
M stage
M0	499	262	237	7.107	0.008**
M1	61	21	40
Clinical stage
0-II	313	179	134	14.305	0.000155***
III-IV	270	112	158
Tumor location
Proximal	232	104	128	3.988	0.046*
Distal	351	187	164
Chemotherapy.adjuvant
Yes	240	115	125	1.467	0.226
NO	326	173	153
mmr.status
dMMR	77	36	41	0.471	0.492
pMMR	459	234	225
Cimp.status
Positive	93	34	59	8.09	0.004**
Negative	420	222	198
Cin.status
Positive	369	191	178	0.029	0.865
Negative	112	59	53
tp53.mutation
Mutant	190	78	112	5.899	0.015*
Wild type	161	87	74
Kras.mutation
Mutant	217	107	110	0.16	0.689
Wild type	328	156	172
Braf.mutation
Wild type	461	230	231
Mutant	51	16	35	6.309	0.012*

ISSN: 1475-2867